The clearance also addresses designs of femoral augments, tibial augments and revision cones, signaling the first step for TJO to enter the revision knee market.
The engineered allogenic osteochondral graft has shown promise in preclinical studies and could benefit people with damaged knee cartilage caused by sports injuries, trauma or post-traumatic arthritis.